Sensei Biotherapeutics (SNSE) Insider Trading & Ownership $0.50 +0.02 (+4.18%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Sensei Biotherapeutics (NASDAQ:SNSE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.00%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$2.07 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$5.44 M Get SNSE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SNSE Insider Buying and Selling by Quarter Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Sensei Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2023John CelebiCEOBuy500$0.85$425.00 6/1/2023Apeiron Investment Group Ltd.Major ShareholderSell3,441,661$1.58$5,437,824.38 2/23/2023Apeiron Investment Group Ltd.Major ShareholderBuy2,200$1.61$3,542.00 3/2/2022James PeyerDirectorBuy1,203$3.20$3,849.60 3/1/2022Cambrian Biopharma IncMajor ShareholderBuy2,458$3.60$8,848.80 2/28/2022James PeyerDirectorBuy42$3.60$151.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/24/2022James PeyerDirectorBuy15,000$3.63$54,450.00 2/23/2022Cambrian Biopharma IncMajor ShareholderBuy2,500$3.80$9,500.00 2/18/2022Cambrian Biopharma IncMajor ShareholderBuy15,000$3.97$59,550.00 2/17/2022James PeyerDirectorBuy4,949$4.17$20,637.33 2/16/2022Cambrian Biopharma IncMajor ShareholderBuy2,551$4.25$10,841.75 2/14/2022Cambrian Biopharma IncMajor ShareholderBuy10,000$4.18$41,800.00 2/11/2022Cambrian Biopharma IncMajor ShareholderBuy12,500$4.40$55,000.00 2/10/2022James PeyerDirectorBuy5,000$4.58$22,900.00 2/8/2022Cambrian Biopharma IncMajor ShareholderBuy10,000$4.33$43,300.00 2/4/2022James PeyerDirectorBuy2,500$4.45$11,125.00 2/3/2022Cambrian Biopharma IncMajor ShareholderBuy17,500$4.65$81,375.00 1/28/2022James PeyerDirectorBuy8,900$4.22$37,558.00 1/27/2022Cambrian Biopharma IncMajor ShareholderBuy6,100$4.31$26,291.00 1/26/2022James PeyerDirectorBuy29,900$4.62$138,138.00 1/25/2022Cambrian Biopharma IncMajor ShareholderBuy20,100$4.86$97,686.00 1/24/2022James PeyerDirectorBuy22,707$4.69$106,495.83 1/21/2022Cambrian Biopharma IncMajor ShareholderBuy24,703$4.94$122,032.82 1/20/2022James PeyerDirectorBuy20,000$5.17$103,400.00 1/19/2022Cambrian Biopharma IncMajor ShareholderBuy10,244$4.97$50,912.68 1/18/2022James PeyerDirectorBuy10,000$5.08$50,800.00 1/14/2022Cambrian Biopharma IncMajor ShareholderBuy6,219$4.99$31,032.81 1/13/2022James PeyerDirectorBuy19,953$5.13$102,358.89 1/12/2022Cambrian Biopharma IncMajor ShareholderBuy9,202$5.22$48,034.44 1/11/2022James PeyerDirectorBuy10,845$5.18$56,177.10 12/29/2021Cambrian Biopharma IncMajor ShareholderBuy69,000$4.98$343,620.00 12/28/2021James PeyerDirectorBuy11,288$5.28$59,600.64 12/27/2021Cambrian Biopharma IncMajor ShareholderBuy3,712$5.30$19,673.60 12/23/2021James PeyerDirectorBuy11,000$5.27$57,970.00 12/17/2021James PeyerDirectorBuy117$5.29$618.93 12/16/2021Cambrian Biopharma IncMajor ShareholderBuy10,925$5.25$57,356.25 12/9/2021Thomas G RicksDirectorBuy20,000$6.62$132,400.00 (Data available from 1/1/2013 forward) SNSE Insider Trading Activity - Frequently Asked Questions Who is on Sensei Biotherapeutics's Insider Roster? The list of insiders at Sensei Biotherapeutics includes Apeiron Investment Group Ltd., Cambrian Biopharma Inc, James Peyer, John Celebi, and Thomas G Ricks. Learn more on insiders at SNSE. What percentage of Sensei Biotherapeutics stock is owned by insiders? 22.00% of Sensei Biotherapeutics stock is owned by insiders. Learn more on SNSE's insider holdings. Which Sensei Biotherapeutics insiders have been buying company stock? The following insiders have purchased SNSE shares in the last 24 months: Apeiron Investment Group Ltd. ($3,542.00), and John Celebi ($425.00). How much insider buying is happening at Sensei Biotherapeutics? Insiders have purchased a total of 2,700 SNSE shares in the last 24 months for a total of $3,967.00 bought. Which Sensei Biotherapeutics insiders have been selling company stock? The following insider sold SNSE shares in the last 24 months: Apeiron Investment Group Ltd. ($5,437,824.38). How much insider selling is happening at Sensei Biotherapeutics? Insiders have sold a total of 3,441,661 Sensei Biotherapeutics shares in the last 24 months for a total of $5,437,824.38 sold. Sensei Biotherapeutics Key ExecutivesMr. John K. Celebi M.B.A. (Age 52)President, CEO & Director Compensation: $882.28kDr. Edward Van der Horst Ph.D. (Age 50)Chief Scientific Officer Compensation: $630.81kMs. Lora PikeVice President of Investor Relations & CommunicationsMr. Christopher W. Gerry J.D.Senior VP, General Counsel & SecretaryMs. Stephanie Krebs M.B.A. (Age 46)M.S., Chief Business Officer Dr. Aaron Weitzman FACPM.D., Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies TXMD Insider Selling TARA Insider Selling DBVT Insider Selling IMMX Insider Selling GANX Insider Selling CALC Insider Selling SCYX Insider Selling SNYR Insider Selling OCX Insider Selling RVPH Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:SNSE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNSE Stock Alerts